Over the past few years, GCCs across different industry verticals have established a strong foothold in the Indian market, with the life sciences sector being particularly notable. Cities like Hyderabad and Bengaluru in Southern India are emerging as key hubs. This growth is driven by a favorable policy environment, a skilled workforce, and robust infrastructure, making the region a prime destination for life sciences and biotech firms. The area offers a strategic advantage for innovation, collaboration, and cost-effective manufacturing. To know more on how you can leverage the GCC momentum for your business, click here: https://bit.ly/3SHFkzN Anshuman Magazine | Ram Chandnani #LifeSciences #Biotech #Innovation #GCCs #SouthernIndia #Bengaluru #Hyderabad #Manufacturing #CBREIndia
CBRE India’s Post
More Relevant Posts
-
Mumbai has the potential to become a leader in biotechnology due to several factors. The city already boasts a robust scientific and research community, with numerous academic institutions, research centers, and biotech companies. The collaborative efforts between academia and industry can foster a fertile environment for innovation.Additionally, Mumbai's well-established healthcare infrastructure, including hospitals and medical research facilities, provides a strong foundation for advancements in biomedicine and pharmaceuticals. The convergence of expertise in these areas positions Mumbai favorably to lead in the development of novel treatments and therapies.The city's economic strength and global connectivity can attract investments and partnerships, accelerating the growth of biotech enterprises. Government support and policies that encourage research and development further contribute to the city's potential to lead in biotechnology.As Mumbai continues to embrace technological advancements and entrepreneurship, it is poised to emerge as a prominent hub for biotech research, development, and commercialization, driving progress not only within the city but also on the global stage. #linkedin #mumbai #biotechnology #growyourbusiness #explorepage
To view or add a comment, sign in
-
At Rx Propellant, we're not just building spaces; we're cultivating #ecosystems where #innovation thrives, collaboration flourishes, and breakthroughs happen. Our mission? To propel India to the forefront of the global #lifescienceindustry. With our cutting-edge labspaces and flexi factories strategically located in Genome Valley - Hyderabad's Life Sciences District, BLR District in #Bengaluru, and Navi Mumbai Research (NMR) District in #Mumbai, we're providing the perfect environment for #scientists, #researchers, #entrepreneurs, and #manufacturers to unleash their potential. In our labs, ideas transform into reality, #experiments lead to #discoveries, and innovations shape the future. But it's not just about bricks and mortar. It's about fostering a community where #knowledge is shared, ideas are nurtured, and #collaborations are forged. As we expand our footprint and presence across the nation, we're determined to take the momentum of the #lifesciences revolution forward. We believe in the power of collective action, the strength of #partnerships, and the impact of collaborative ecosystems. Together, we can inspire confidence, drive #research, and accelerate #development. Join us in shaping the future of life sciences in India. Let's ignite innovation, unlock potential, and build a brighter tomorrow – together. Vishal Goel, Milind Ravi
Your Compliant Life Science Hub
To view or add a comment, sign in
-
The small and medium-sized business sector in Hyderabad is critical to the success of its industries. In engineering, SMBs in Balanagar and Jeedimetla are pushing precise manufacturing innovation, notably in aerospace and defence. A recent development is the expansion of Tata Advanced Systems in Hyderabad to increase aircraft component production. The biotechnology industry, centered on Genome Valley, sees SMBs driving vaccine research and pharmaceutical manufacture, with Bharat Biotech's ongoing development of next-generation vaccines emphasizing Hyderabad's biotech prowess. SMBs in Madhapur and Gachibowli provide specialized software and cloud services to global giants like as Microsoft and Google. Hyderabad has recently emerged as the second-largest contributor to India's data center growth, with SMBs helping to fuel this boom. Together, these verticals, which are powered by SMBs, establish Hyderabad as a leader in innovation and industrial growth. #IndiaSMB #BusinessGrowth#SMB #MakeinIndia #Hyderabad #Biotechnology #Engineering #InformationTechnology arindam dey Ram Goswami Writuparna Phalguni Dutta POOJA G. Sarthak Pandey AROHI TOSHNIWAL Aniketh Debroy Nidhi Srivastava
To view or add a comment, sign in
-
"Excited to share this incredible opportunity! A one-day workshop on electrochemical sensor devices is being organized by the Department of Medical Devices, NIPER Ahmedabad, in collaboration with Metrohm India. Dive into the latest advancements and trends in this cutting-edge field. Mark your calendar for December 16, 2024! Don't miss out—register now! #Research #Innovation #MedicalDevices"
We are thrilled to announce a one-day workshop on electrochemical sensor devices organized by the Department of Medical Devices, NIPER Ahmedabad supported by Metrohm India Private Limited on 16 December 2024. Focus of this #workshop will be on the latest advancements, practical applications, and emerging trends in the field of electrochemical sensors. It's a great opportunity for #researchers, #students, and #professionals to gain insights and network with experts in the domain. 📅 Date: 16/12/2024 🕘 Time: 09:00 am - 5:30 pm 📍 Venue: Auditorium, Old building, NIPER-Ahmedabad,382355. 🔗 Register here: https://lnkd.in/essNfVBB For more details contact: Dr. Suveen Kumar 📞 +91 95600 46859 📧 suveen.kumar@niperahm.res.in #DOMD #medicaldevices #niperahmedabad #workshop #electrochemicalsensors
To view or add a comment, sign in
-
Biosensors for Point-of-Care Testing Market 𝐒𝐢𝐳𝐞 𝐀𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 Biosensors for Point-of-Care Testing Market size is expected to develop revenue and exponential market growth at a remarkable CAGR during the forecast period from 2024–2031. The comprehensive report of the Biosensors for Point-of-Care Testing Market will analyse data changes and their impact on the market at the global level. It also analyses the overall growth of companies in the market and their abilities to manage and control profit levels, which is highly important to any investor wishing to open and expand a company within the same market. ➢𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐦𝐞𝐧𝐭𝐢𝐨𝐧𝐞𝐝 𝐚𝐬 𝐛𝐞𝐥𝐨𝐰: ➢➢ Biosensors International Group, Ltd ➢ IEEE BioSensors ➢ Current Health ➢ iRhythm Technologies, Inc. ➢ ForteBio ➢ IDS Medical Systems (idsMED) ➢ SCHOTT MINIFAB ➢ Innovative Sensor Technology IST AG ➢ Shenzhen Prunus Medical Co.,Ltd. ➢ Tampere University, Faculty of Medicine and Health Technology ➢ Octet®- Affinity, Binding Kinetics and Concentration ➢ Sensa Core Medical Instrumentation Pvt. Ltd. ➢ AgaMatrix ➢ Vis-À-Vis Health ➢ Institute of Science - Banaras Hindu University ➢ VivaChek Biotech ➢ NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI) ➢ Stripe Conferences ➢ Bluesail Medical ➢ Opteev ➢ Information Technology Institute (ITI) ➢ Information Technology Institute (ITI) ➢ Information Technology Industry Development Agency, ITIDA ➢ General Dynamics Information Technology ➢ Raya Information Technology ➢ Dev Information Technology Limited ➢ Ministry of Communications and Information Technology (MCIT), Egypt ➢ Indraprastha Institute of Information Technology, Delhi ➢ International Institute of Information Technology Bangalore ➢ Indian Institute Of Information Technology Allahabad ➢ International Institute of Information Technology Hyderabad (IIITH) ➢ COMSATS Institute of Information and Technology ➢ Ministry of Communications and Information Technology (MCIT), Egypt ➢ Jaypee Institute Of Information Technology ➢ PT. Astra Graphia Information Technology (AGIT) ➢ ReBIT | Reserve Bank Information Technology Pvt. Ltd. ➢ Sarhad University of Science and Information Technology ➢ NATIONAL INSTITUTE OF ELECTRONICS & INFORMATION TECHNOLOGY (NIELIT) ➢ Technology Ventures ➢ Information & eGovernment Authority #data #sales #marketresearch #research #entrepreneur #businessstrategy #technology #data #sales #datacollection #salesfunnel #contentmarketing #bhfyp #size #forecast # #Share #Scope #Opportunities #Analysis #BiosensorsforPoint-of-CareTesting
To view or add a comment, sign in
-
The need for #sustainable infrastructure and #green buildings in the #lifesciences sector has never been more critical. As we push the boundaries of scientific #innovation, it's essential to do so responsibly, ensuring that our progress today doesn't compromise the world of tomorrow. At Rx Propellant, we are committed to this vision through our "Future Ready" concept, which integrates #sustainability into every facet of our projects. A shining example is our Navi Mumbai Research (NMR) District. Here, we are creating a sustainable #ecosystem for lifesciences R&D that not only supports cutting-edge #research but also minimizes environmental impact. By prioritizing #energy efficiency, waste reduction, and green building practices, we are setting a new standard for life sciences facilities. Together, let's create a future where scientific advancement and environmental stewardship go hand in hand. For more information on Navi Mumbai Research (NMR) District's sustainability initiatives: https://lnkd.in/gB4T_qVA #GreenBuilding #RxPropellant #Innovation #EnvironmentalStewardship #ecofriendly #sustainableinfrastructure #infrastructure #lifescience #pharma #biotech #CRO #CDMO #labspace #manufacturing
To view or add a comment, sign in
-
India’s Role in Healthcare & Life Sciences GCCs 🌟 🌍 India: A #Global Leader in #Healthcare & Life Sciences Innovation 🧬 India is solidifying its position as a global powerhouse for Healthcare and Life Sciences Global Capability Centers (#GCCs). With 95+ GCCs, employing 280,000+ professionals, the nation is spearheading advancements in R&D, clinical trials, and healthcare technology. 📊 Key Insights: -15% of GCC talent in India is dedicated to healthcare and life sciences. -Bengaluru leads with 33% of India’s Healthcare GCCs, followed by Hyderabad (20%) and Mumbai (19%). -Hyderabad accounts for 35% of India's pharmaceutical production and is home to 200+ US FDA-approved sites, making it a hub for life sciences innovation. -800+ pharma and biotech companies operate in Hyderabad, valued at $50+ billion. -85% of life sciences GCCs are concentrated in Bengaluru, Hyderabad, Mumbai, and Delhi/NCR, underscoring India’s strategic advantage. 💡 Driving Forces Behind India’s Success: -Innovation & Technology: AI, ML, and data analytics are revolutionizing healthcare. GCCs contribute to drug discovery, clinical data analysis, and personalized medicine, enabling faster, cost-effective solutions. -Talent Pool: With 1.5M STEM graduates annually, India provides unmatched access to skilled professionals in life sciences, digital, and engineering. Cost Efficiency: Indian GCCs offer 40–60% cost savings compared to Western counterparts, ensuring scalability -Government Support: Initiatives like Make in India, Pharma City, and Genome Valley attract global leaders to invest in cutting-edge R&D. 🌟 Global Leaders & Impact: Companies are leveraging India’s GCCs for: Accelerated drug discovery and clinical trial management. Advanced technologies such as AI-driven imaging, cloud solutions, and real-world evidence analytics. Contributions to 400+ patents and state-of-the-art innovation hubs 🔗 #HealthcareInnovation #LifeSciences #GlobalCapabilityCenters #India #IndianGCC #GCC #AIinHealthcare #PharmaLeadership #InnovationHub #Bengaluru #jobseeker #job #Hyderabad #DigitalHealthcare #R&DTransformation #GlobalLeadership Source: https://lnkd.in/g2uzG8rT
To view or add a comment, sign in
-
Honored to present my research project at the "National Level Article Presentation Competition" held at SVERI College of Pharmacy, Pandharpur and Academic Decipher, Mumbai. It was an inspiring experience to engage with fellow researchers, exchange insights, and receive valuable feedback on our work. Grateful for the opportunity to showcase our findings and contribute to advancements.Looking forward to more such opportunities to learn, grow, and make an impact! #ResearchExcellence #Innovation #NationalCompetition #ScientificCommunity"
To view or add a comment, sign in
-
Do you believe that Indians don’t need to rely on other countries for their needs? Most of our healthcare manufacturing is based on imports even when we have the potential to fulfill them in our country. While building Medorah Meditek Pvt Ltd, I am constantly in awe of the growth and potential within India's manufacturing sector. Here is how we are self-sufficient in one of the best ways possible: → India has one of the most cost-effective manufacturing environments. The cost of labor is significantly lower than in many Western countries, allowing for competitive pricing without compromising on quality. → India has a strong network of talented and skilled professionals with over 1.5 million engineers graduating annually. This ensures that our manufacturing processes are not only efficient but also innovative. → The Indian government has launched several initiatives like "Make in India" and "Production Linked Incentive Scheme" to support the manufacturing sector with financial incentives, ease of doing business, and infrastructure development. → India's focus on adopting Industry 4.0 technologies, such as AI and robotics is transforming manufacturing processes. Several companies have integrated these to monitor production in real-time, ensuring higher efficiency and lower waste. These make India not just a manufacturing hub but a global leader that can take over in the coming years. It's our pleasure to be contributing to India's manufacturing excellence in various ways in the healthcare sector. What do you think about India’s manufacturing capabilities? #healthcare #manufacturing
To view or add a comment, sign in
-
I am thrilled to share insights from the recently concluded Global Bio-India 2024, held from September 12-14 at Pragati Maidan, New Delhi. This year's event, organized by the Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC), brought together a vibrant community of national and international stakeholders in the biotechnology sector. The theme of this year’s event, “Biotech Innovation and Bio-manufacturing,” emphasized India's growing capabilities and potential as a global hub for biotech research and manufacturing. The event featured:Launch of 11 Innovative Products: Indian biotech startups showcased groundbreaking products that underline our country's emerging talent in biosciences. Networking Opportunities: The event facilitated meaningful interactions among industry leaders, researchers, and investors, paving the way for future collaborations. In an era where data is at the core of biotechnology advancements, protecting sensitive information has never been more crucial. Biotech companies handle vast amounts of sensitive data, including patient information and proprietary research. Ensuring robust data protection measures is essential not only for compliance with regulations but also for maintaining trust with stakeholders.The recent discussions at Global Bio-India highlighted the importance of implementing stringent data privacy practices to safeguard intellectual property and patient data. As we innovate, let’s prioritize data security to prevent breaches that could compromise research integrity and patient confidentiality. As we look ahead, initiatives like the #BioE3Policy aim to position India as a global powerhouse in biotechnology, focusing on sustainable development and job creation. Kudos to everyone involved in making this event a success! Let’s continue to drive innovation and explore new horizons in biotechnology together. 💡🔬#GlobalBioIndia2024 #Biotechnology #Innovation #DataProtection #BioManufacturing #IndiaBiotech #Networking #Collaboration #SustainableDevelopment
To view or add a comment, sign in
159,673 followers